| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e399db09307cc272ac790556c37b7ba |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-09 |
| filingDate |
2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ca81708a4d295a8a178524122055125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de2b6e1fac4735f63dd8fb8676b07fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be496aa46d58ce535e6dfd3a4b44662b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f86b406913ea7c05fd5380fdec1983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fa4231649798b131d639e59bb77ec9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a83d0c0a31b6025e1dc80dec8d5a1de |
| publicationDate |
2022-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2924710-T3 |
| titleOfInvention |
Nicotinamide riboside for use in treating or preventing liver damage |
| abstract |
Provided herein are compositions comprising nicotinamide riboside and optionally pterostilbene, for use in the treatment and/or prevention of liver-related diseases and disorders and for improving liver health in a subject by administration to the subject (p. eg, oral administration to the subject) of said composition. (Automatic translation with Google Translate, without legal value) |
| priorityDate |
2017-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |